Minimally Invasive Vertebral Compression Fracture Treatment Global Market Report 2024

The minimally invasive vertebral compression fracture treatment market size has grown rapidly in recent years. It will grow from $1.22 billion in 2023 to $1.34 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth witnessed in the historical period can be attributed to various factors, such as the increased incidence of vertebral compression fractures, advancements in surgical devices, a rising demand for minimally invasive procedures, the growth of the aging population, and economic factors influencing healthcare decisions and investments.

The minimally invasive vertebral compression fracture treatment market size is expected to see strong growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The projected growth in the forecast period is driven by several factors, including the increasing awareness and education levels, the rise of emerging markets, advancements in imaging technologies, growing investments in research and development, and the presence of supportive regulatory frameworks. Major trends anticipated during this period encompass product innovations, strategic partnerships, and continuous technological advancements. These trends reflect the evolving landscape of industries, indicating a focus on innovation and collaboration to meet evolving consumer needs and regulatory requirements.

The anticipated increase in osteoporosis prevalence is projected to drive the expansion of the minimally invasive vertebral compression fracture treatment market in the foreseeable future. Osteoporosis, a medical condition characterized by weakened bones and decreased bone density, heightens the risk of fractures. The adoption of minimally invasive vertebral compression fracture treatments in osteoporosis management represents an advanced and efficacious approach aimed at improving patient outcomes and well-being. For instance, a December 2023 report from the Australian Institute of Health and Welfare (AIHW), an Australian government agency, revealed that osteoporosis contributed to 2,366 deaths in 2021, with a rate of 6.5 deaths per 100,000 population, accounting for 1.4% of all deaths. Additionally, in 2021-22, there were 9,500 hospitalizations with a principal diagnosis of osteoporosis among individuals aged 45 and above, representing 89 hospitalizations per 100,000 population. Consequently, the escalating prevalence of osteoporosis is fostering the growth of the minimally invasive vertebral compression fracture treatment market.

Major players in the minimally invasive vertebral compression fracture treatment market are dedicated to advancing technologies, including access retractor systems, to better serve customers with enhanced functionalities. Minimally invasive access retractor systems are medical devices designed to facilitate less invasive surgical procedures by enabling access to target areas with minimal tissue disruption, typically through small incisions or natural body openings. For example, in April 2023, Orthofix Medical Inc., a US-based medical device company, introduced two access retractor systems tailored to aid surgeons in minimally invasive spine (MIS) procedures. The Lattus Lateral Access System and Fathom Pedicle-Based Retractor System augment the company's access solutions. The Lattus system offers ease of use and versatility, featuring independent blade retraction strength and a unique down-and-out splay feature for challenging anatomy access. Meanwhile, the Fathom Retractor, equipped with three points of active telescoping blade fixation, allows surgeons to customize lateral to medial tilt for a precise and rigid construct, thereby promoting optimal outcomes in MIS procedures. Both systems enhance surgical workflow, improve visualization, and complement Orthofix's comprehensive procedural solutions.

In October 2022, Halma plc, a UK-based life-saving technology company, completed the acquisition of IZI Medical Products for $175.43 million. This strategic move bolsters Halma's aim to broaden its portfolio into products supporting minimally invasive diagnosis and treatment, particularly within the realm of interventional spine procedures. IZI Medical Products, a US-based medical equipment manufacturing company, specializes in the development of minimally invasive solutions, aligning with Halma's expansion objectives in the healthcare sector.

Major companies operating in the minimally invasive vertebral compression fracture treatment market report are Cigna Healthcare, Johnson & Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet, Halma Plc, Hoag Orthopedic Institute, Merit Medical Systems, Globus Medical, Orthofix Medical Inc., Aesculap Implant Systems LLC, Alphatec Holdings Inc., RTI Surgical, OrthoPediatrics Corp., OsteoMed L.P., Spine Wave Inc., CoreLink Surgical, Tyber Medical LLC, ZAVATION, Vexim SA, Benvenue Medical, Joimax GmbH, Osseon Therapeutics, Spirit Spine Holding Corporation Inc., Joline GmbH and Co. KG, CareFusion Corporation, Lindare Medical Ltd.

North America was the largest region in the minimally invasive vertebral compression fracture treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive vertebral compression fracture treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the minimally invasive vertebral compression fracture treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Minimally invasive vertebral compression fracture treatment encompasses a range of medical procedures employing minimally invasive techniques to stabilize and mend fractured vertebrae in the spine, with the goal of stabilizing the fractures and alleviating associated pain.

The primary surgical modalities within this treatment approach comprise minimally invasive spine surgery (MISS) and open spine surgery. MISS involves surgical interventions on the spinal bones utilizing smaller incisions compared to conventional surgery, resulting in reduced damage to surrounding muscles and tissues, thereby potentially leading to less postoperative pain and quicker recovery times. Various technologies are employed in these procedures, including balloon kyphoplasty and vertebroplasty, catering to multiple end-users such as hospitals and ambulatory surgery centers (ASCs).

The minimally invasive vertebral compression fracture treatment research report is one of a series of new reports that provides minimally invasive vertebral compression fracture treatment market statistics, including the minimally invasive vertebral compression fracture treatment industry's global market size, regional shares, competitors with an minimally invasive vertebral compression fracture treatment market share, detailed minimally invasive vertebral compression fracture treatment market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive vertebral compression fracture treatment industry. This minimally invasive vertebral compression fracture treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The minimally invasive vertebral compression fracture treatment market includes revenues earned by entities offering bone cement augmentation, radiofrequency ablation (RFA), percutaneous vertebroplasty, and vertebral augmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The minimally invasive vertebral compression fracture treatment market also includes sales of vertebroplasty needles and instruments, vertebroplasty systems, bone cement, and fracture reduction systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.